Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SWS Hemodialysis Care CoSHSE:688410 +1.62%84 Days Payable is 128.22 as of Jun. 2026, which is 51% above its 10-year median of 85.11. GuruFocus rates SHSE:688410 with a GF Score™ of 84/100 and a GF Value™ of ¥18.08 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 797 Medical Devices & Instruments companies, SWS Hemodialysis Care Co ranks better than 78.92% on this metric.
The historical rank and industry rank for SWS Hemodialysis Care Co's Days Payable or its related term are showing as below:
SHSE:688410'
s Days Payable Range Over the Past 10 Years
Min: 50.88 Med: 85.11 Max: 157.08
Current: 157.08
During the past 7 years, SWS Hemodialysis Care Co's highest Days Payable was 157.08. The lowest was 50.88. And the median was 85.11.
SHSE:688410's Days Payable is ranked better than 78.92% of 797
companies
in the Medical Devices & Instruments industry
Industry Median: 69.48
vs SHSE:688410: 157.08
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688410 vs ISRG, BDX, RMD: Days Payable Comparison
For the Medical Devices subindustry, SWS Hemodialysis Care Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SWS Hemodialysis Care Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SWS Hemodialysis Care Co's Days Payable distribution charts can be found below:
* The bar in red indicates where SWS Hemodialysis Care Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
SWS Hemodialysis Care Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SWS Hemodialysis Care Co (SHSE:688410) has a Days Payable of 128.22 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SWS Hemodialysis Care Co and its competitors. This is 51% above median its historical median of 85.11. Over the past decade, SWS Hemodialysis Care Co's Days Payable has ranged from 50.88 to 157.08. According to the industry distribution chart, SWS Hemodialysis Care Co ranks #168 out of 797 companies in the Medical Devices & Instruments industry, placing it in the top 21.1%.
Is SWS Hemodialysis Care Co's Days Payable too high?
SWS Hemodialysis Care Co's current Days Payable of 128.22 is 51% above median its 10-year median of 85.11. Over the past 10 years, this metric has ranged from a low of 50.88 to a high of 157.08. The Medical Devices & Instruments industry median Days Payable is 69.48. SWS Hemodialysis Care Co's value of 128.22 is 84.5% above this industry median. Based on the distribution chart, SWS Hemodialysis Care Co ranks #168 out of 797 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, SWS Hemodialysis Care Co has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SWS Hemodialysis Care Co's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SWS Hemodialysis Care Co ranks #168 out of 797 companies for Days Payable. This places SWS Hemodialysis Care Co in the top 21% of its industry — outperforming the majority of peers. The industry median Days Payable is 69.48. SWS Hemodialysis Care Co's value of 128.22 is 84.5% above this benchmark. Historically, SWS Hemodialysis Care Co's own Days Payable has ranged from 50.88 to 157.08 over the past decade. While the company's 10-year median is 85.11 vs. the industry median of 69.48, SWS Hemodialysis Care Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 69.48, based on 797 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SWS Hemodialysis Care Co's current Days Payable of 128.22 is 84.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SWS Hemodialysis Care Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 69.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SWS Hemodialysis Care Co's current Days Payable is 128.22, which is 51% above median its own 10-year median of 85.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SWS Hemodialysis Care Co stock overvalued right now?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co (SHSE:688410) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥18.08, compared to a current price of ¥9.42 — trading 47.9% below its estimated fair value. The current Days Payable is 128.22, which is 51% above median its 10-year median of 85.11 and 84.5% above the Medical Devices & Instruments industry median of 69.48. SWS Hemodialysis Care Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For SWS Hemodialysis Care Co (SHSE:688410), the current Days Payable is 128.22 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SWS Hemodialysis Care Co (SHSE:688410) Overvalued in 2026?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co stock appears to be undervalued.
The current stock price of ¥9.42 is trading 47.9% below its estimated GF Value™ of ¥18.08.
GuruFocus considers SWS Hemodialysis Care Co to be Significantly Undervalued.
Key valuation signals for SHSE:688410:
Days Payable: 128.22 (51% above median its 10-year median of 85.11)
GF Value™: ¥18.08 vs. price of ¥9.42 (47.9% below fair value)
Industry Position: 84.5% above the Medical Devices & Instruments median (#168 of 797)
No single metric tells the full story. See the SHSE:688410 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SWS Hemodialysis Care Co Ltd along with its subsidiaries is engaged in the field of blood purification. Its focused on patients welfare and ensuring the delivery of safe and effective products and services. The group operates through four segments: Blood Purification Equipment, Blood Purification Consumables, advanced Hemodialysis Management System, and Chain Dialysis centers. The organization is delivering medical solutions for patients with chronic kidney disease (CKD). Its products include Blood Purification Equipment Dialysis, Disposables Dialysis Center, Intelligent Management System, and Chain Dialysis centers. SWS is committed to enhancing patient wellness by prioritizing care through advanced integrated blood purification technologies.
84GF Score
Get the complete analysis for SHSE:688410
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688410 has been successfully added to your 
